Q1 2024 Blueprint Medicines Corp Earnings Call Transcript
Good morning. My name is Faye, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Blueprint Medicines first quarter 2024 financial results conference call. (Operator instructions) Thank you. Jenna Cohen, you may begin your conference.
Thanks, Faye, and good morning, everyone. Welcome to Blueprint Medicines first quarter 2024 financial and operating results conference call. This morning, we issued a press release which outlines the topics we plan to discuss today. You can access the press release as well as the slides that will be reviewing today by going to the Investors section of our website at www.Blueprint Medicines.com.
Joining me today are Kate Haviland, Chief Executive Officer; Philina Lee, Chief Commercial Officer; Fouad Namouni, President, Research and Development; and Mike Landsittel, Chief Financial Officer. Christy Rossi, Chief Operating Officer; and Becker Hewes, Chief Medical Officer, are also on the line and available
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |